Ask AI
ProCE Banner Activity

Advancing Hemophilia Care: Uniting Expert Insights and Community Voices to Shape the Future of Non-Factor Replacement Therapy

Slideset

Download these slides to learn more about novel and emerging non-factor replacement therapies for moderate to severe hemophilia and develop personalized treatment strategies to optimize patient care in your clinical practice.

Released: December 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Target Audience

This activity has been designed to meet the educational needs of hematologists and other healthcare professionals who manage patients with hemophilia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Compare the clinical profiles of novel and emerging therapies for moderate to severe hemophilia

  • Develop individualized prophylaxis management strategies for patients with moderate to severe hemophilia based on current evidence for new and emerging treatments

  • Identify patients who are at high risk for developing debilitating sequalae of moderate to severe hemophilia such as hemophilic arthropathy in order to select prophylaxis strategies that optimize quality of life

  • Apply efficacy and safety data for current and emerging non-factor replacement therapies in moderate to severe hemophilia to clinical practice